| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Lingnau Lutz is a Director at NEKTAR THERAPEUTICS. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $2.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 27, 2019 | NKTR Nektar Therapeutics | Director | Sell | 3,000 | $17.84 | $53,520.00 | -10.1% | |
| Jul 8, 2019 | NKTR Nektar Therapeutics | Director | Sale+OE | 10,000 | $34.63 | $346,300.00 | -30.1% | |
| Sep 20, 2018 | NKTR Nektar Therapeutics | Director | Sell | 9,000 | $56.98 | $512,820.00 | -32.8% | |
| Apr 5, 2018 | NKTR Nektar Therapeutics | Director | Sale+OE | 30,000 | $101.74 | $3,052,200.00 | -52.2% | |
| Sep 22, 2017 | NKTR Nektar Therapeutics | Director | Sell | 5,000 | $21.97 | $109,850.00 | -15.4% | |
| Jul 14, 2017 | NKTR Nektar Therapeutics | Director | Sale+OE | 30,000 | $20.76 | $622,800.00 | -56.1% | |
| Apr 7, 2017 | NKTR Nektar Therapeutics | Director | Sell | 7,000 | $20.05 | $140,350.00 | -23.0% | |
| Feb 21, 2017 | NKTR Nektar Therapeutics | Director | Sale+OE | 30,000 | $13.08 | $392,400.00 | -49.6% | |
| Sep 15, 2016 | NKTR Nektar Therapeutics | Director | Sale+OE | 9,000 | $19.06 | $171,540.00 | -54.7% | |
| Apr 25, 2016 | NKTR Nektar Therapeutics | Director | Sale+OE | 15,000 | $16.27 | $244,050.00 | -47.7% |